GTBP News and Press, GT Biopharma Inc. From 06/08/21

GT Biopharma to be Added to the Russell 2000® Index PR Newswire BEVERLY HILLS, Calif. , June 8, 2021 /PRNewswire/ -- GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing ...

These Former Penny Stocks Are Surging In June & AMC Stock May’ve Helped When it comes to penny stocks, no others have clearly demonstrated the potential better than AMC stock & GameStop. This year has been one for the record books. While 2020 was all about recovery an...

GT Biopharma, Inc.’s (GTBP) stock has more than quintupled since it began providing data from a Phase 1 trial evaluating its only clinical asset (GTB-3550) in the treatment of AML. Bone marrow blast reductions were observed in three of five patients in the higher dose cohorts w...

Meme Stocks Mania Captivated Traders But Haven’t Been The Only Ones To Watch This Year This year is an unprecedented one for penny stocks and blue chips alike. Whether we’re talking about the latest meme stocks like GameStop ( NYSE: GME ) and AMC Entertainment ( NYSE...

Were These Former Penny Stocks On Your Reddit Watch List This Month? This year has brought a fresh perspective on what it means to trade the markets. Thanks to Reddit, penny stocks have grown in popularity and, in many cases, legitimacy. Who can forget the rise of GameStop stock in Janu...

Hot Current & Former Penny Stocks To Watch Right Now Is it crazy to think that investing in penny stocks is worth it? Based on mainstream sentiment, these cheap stocks are “built for speed.” But when it comes to a buy and hold strategy, your average trader says to stay...

Biotech Stocks Remain A Core Focus For Traders This Year Penny stocks are well-known for their volatility. In one moment, you can see them gaining hundreds of percentage points. Then the next moment, you see them hitting new lows. Is this the case for all penny stocks ? No, but this...

Biotech Penny Stocks To Watch After Bullish Analyst Ratings This weekend we discussed how analyst ratings could play a role with penny stocks. Also, reports that accompany them shed light on the future outlook and potential catalysts these firms have an interest in. When it comes to fin...

MorphoSys upgraded at Morgan Stanley citing the potential of MonjuviMorphoSys (MOR) has lost ~23.8% in the year so far. Noting that the pullback has brought the shares towards its bear case value, Morgan Stanley analysts have upgraded the stock to overweight from equal-weight.The price target...

These Current & Former Penny Stocks Are Making Their Mark In 2021 Penny stocks have been a big focus for retail traders over the last few years. In fact, if you look at any of the top small-cap stock ETFs, the trend is clear right now. Since the depths of the pandemic drop, the Russ...